We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novadaq Contracts for European Distribution with Kodak

By HospiMedica staff writers
Posted on 20 Sep 2006
Novadaq Technologies, Inc. More...
(Toronto, Canada), a developer of medical imaging systems for the operating room, has signed an agreement with Eastman Kodak Co. (Rochester, NY, USA), authorizing Kodak to be the sole European and emerging-markets distributor of Novadaq's Spy intra-operative imaging system, which enables cardiac surgeons to visually assess coronary vasculature and bypass graft functionality during the course of open-heart surgery.

Under the agreement, Kodak will sell Novadaq's Spy system directly and through dealers to healthcare providers across Europe and emerging markets. "Cardiac surgeons have seen the significant benefits the Spy system provides during cardiac surgery, including coronary artery bypass graft surgery, which is one of the most challenging surgeries performed,” said Dr. Arun Menawat, president and CEO of Novadaq Technologies, Inc. "With Kodak's worldwide presence in the medical imaging market, we expect to see a successful rollout of the Spy system in Europe and emerging markets just as we have in the U.S.”

"Kodak has strong relationships with physicians and hospitals throughout the world and an experienced and knowledgeable sales force that healthcare providers trust,” said Gordon Moore, product line manager, MVES Surgical Imaging. "Together our companies will strive to accelerate the acceptance of the Spy system to make it the standard of care during cardiac surgery.”

Novadaq's Spy system is a fluorescent imaging system that enables cardiac surgeons to assess coronary vasculature, and to identify and revise anatomic and technical deficiencies while the patient is still in the operating room.

In 2005, Novadaq selected Kodak as the sole U.S. service provider for the Spy system, based on its expertise in medical imaging and geographic coverage offered by its extensive Services organization. Kodak currently is servicing an installed base of Spy systems in over 50 leading healthcare facilities in the United States.



Related Links:
Novadaq Technologies
Eastman Kodak

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.